<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Target Identification - Detailed</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 20px;
        }
        
        .slide {
            width: 960px;
            min-height: 540px;
            margin: 0 auto 30px;
            padding: 40px 60px;
            background: white;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            page-break-after: always;
        }
        
        .title {
            font-size: 36px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .subtitle {
            font-size: 28px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 20px;
            border-bottom: 3px solid #1E64C8;
            padding-bottom: 10px;
        }
        
        .visual-diagram {
            display: flex;
            justify-content: center;
            align-items: center;
            margin-bottom: 20px;
        }
        
        .content-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 15px;
        }
        
        .content-card {
            background: #f8f9fa;
            border-left: 4px solid #1E64C8;
            border-radius: 8px;
            padding: 14px 20px;
            transition: all 0.3s;
        }
        
        .content-card:hover {
            background: #e8f2ff;
            transform: translateX(5px);
            box-shadow: 0 4px 12px rgba(30, 100, 200, 0.15);
        }
        
        .content-main {
            font-size: 18px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 4px;
        }
        
        .content-desc {
            font-size: 14px;
            color: #555;
            font-weight: 400;
        }

        .detail-section {
            margin-top: 25px;
        }

        .detail-box {
            background: linear-gradient(135deg, #f8f9fa 0%, #e8f2ff 100%);
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 15px;
            border-left: 5px solid #1E64C8;
        }

        .detail-title {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 10px;
        }

        .detail-text {
            font-size: 15px;
            color: #333;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .example-box {
            background: #fff3cd;
            border-left: 4px solid #ffc107;
            padding: 12px 15px;
            margin-top: 10px;
            border-radius: 6px;
        }

        .example-title {
            font-weight: 600;
            color: #856404;
            margin-bottom: 5px;
        }

        .example-text {
            font-size: 14px;
            color: #856404;
        }

        .bullet-list {
            margin-left: 20px;
            margin-top: 10px;
        }

        .bullet-list li {
            font-size: 14px;
            color: #444;
            line-height: 1.8;
            margin-bottom: 5px;
        }

        .process-icon {
            animation: pulse 2s ease-in-out infinite;
        }

        @keyframes pulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.7; }
        }

        .arrow-animate {
            animation: flow 2s ease-in-out infinite;
        }

        @keyframes flow {
            0%, 100% { stroke-dashoffset: 0; }
            50% { stroke-dashoffset: 10; }
        }

        .diagram-container {
            display: flex;
            justify-content: center;
            margin: 20px 0;
        }

        .key-point {
            background: #e3f2fd;
            border-left: 4px solid #2196F3;
            padding: 12px 15px;
            margin: 10px 0;
            border-radius: 6px;
        }

        .key-point-text {
            font-size: 15px;
            color: #1565c0;
            font-weight: 500;
        }

        @media print {
            body {
                background: white;
                padding: 0;
            }
            .slide {
                box-shadow: none;
                margin: 0;
                page-break-after: always;
            }
        }
    </style>
</head>
<body>
    <!-- Slide 1: Overview -->
    <div class="slide">
        <div class="title">Target Identification</div>
        
        <div class="visual-diagram">
            <svg width="860" height="140" viewBox="0 0 860 140">
                <!-- Disease -->
                <g>
                    <circle cx="70" cy="70" r="45" fill="#ff6b6b" opacity="0.2"/>
                    <circle cx="70" cy="70" r="35" fill="#ff6b6b" opacity="0.4" class="process-icon"/>
                    <text x="70" y="65" text-anchor="middle" font-size="32" fill="#ff6b6b">ü¶†</text>
                    <text x="70" y="110" text-anchor="middle" font-size="14" font-weight="600" fill="#333">Disease</text>
                </g>

                <!-- Arrow 1 -->
                <line x1="120" y1="70" x2="180" y2="70" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowhead)" stroke-dasharray="5,5" class="arrow-animate"/>

                <!-- Genome -->
                <g>
                    <rect x="190" y="35" width="90" height="70" rx="8" fill="#4ecdc4" opacity="0.2"/>
                    <rect x="195" y="40" width="80" height="60" rx="6" fill="#4ecdc4" opacity="0.4" class="process-icon"/>
                    <text x="235" y="65" text-anchor="middle" font-size="28" fill="#4ecdc4">üß¨</text>
                    <text x="235" y="90" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Druggable</text>
                    <text x="235" y="105" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Genome</text>
                </g>

                <!-- Arrow 2 -->
                <line x1="285" y1="70" x2="345" y2="70" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowhead)" stroke-dasharray="5,5" class="arrow-animate"/>

                <!-- Target -->
                <g>
                    <circle cx="400" cy="70" r="45" fill="#95e1d3" opacity="0.2"/>
                    <circle cx="400" cy="70" r="35" fill="#95e1d3" opacity="0.4" class="process-icon"/>
                    <text x="400" y="65" text-anchor="middle" font-size="32" fill="#2d6a4f">üéØ</text>
                    <text x="400" y="110" text-anchor="middle" font-size="14" font-weight="600" fill="#333">Target</text>
                </g>

                <!-- Arrow 3 -->
                <line x1="450" y1="70" x2="510" y2="70" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowhead)" stroke-dasharray="5,5" class="arrow-animate"/>

                <!-- Validation -->
                <g>
                    <rect x="520" y="35" width="90" height="70" rx="8" fill="#a8dadc" opacity="0.2"/>
                    <rect x="525" y="40" width="80" height="60" rx="6" fill="#a8dadc" opacity="0.4" class="process-icon"/>
                    <text x="565" y="65" text-anchor="middle" font-size="28" fill="#457b9d">‚úì</text>
                    <text x="565" y="90" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Validation</text>
                </g>

                <!-- Arrow 4 -->
                <line x1="615" y1="70" x2="675" y2="70" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowhead)" stroke-dasharray="5,5" class="arrow-animate"/>

                <!-- Network -->
                <g>
                    <circle cx="730" cy="70" r="45" fill="#f4a261" opacity="0.2"/>
                    <circle cx="730" cy="70" r="35" fill="#f4a261" opacity="0.4" class="process-icon"/>
                    <text x="730" y="65" text-anchor="middle" font-size="28" fill="#e76f51">üï∏Ô∏è</text>
                    <text x="730" y="110" text-anchor="middle" font-size="14" font-weight="600" fill="#333">Network</text>
                </g>

                <!-- Arrow marker definition -->
                <defs>
                    <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#1E64C8"/>
                    </marker>
                </defs>
            </svg>
        </div>
        
        <div class="content-grid">
            <div class="content-card">
                <div class="content-main">Disease mechanisms</div>
                <div class="content-desc">Understanding biological pathways</div>
            </div>
            <div class="content-card">
                <div class="content-main">Druggable genome</div>
                <div class="content-desc">Identifying targetable proteins</div>
            </div>
            <div class="content-card">
                <div class="content-main">Target validation</div>
                <div class="content-desc">Confirming therapeutic relevance</div>
            </div>
            <div class="content-card">
                <div class="content-main">Genetic evidence</div>
                <div class="content-desc">Human genetics support</div>
            </div>
            <div class="content-card">
                <div class="content-main">Network approaches</div>
                <div class="content-desc">Systems biology integration</div>
            </div>
        </div>
    </div>

    <!-- Slide 2: Disease Mechanisms -->
    <div class="slide">
        <div class="subtitle">1. Disease Mechanisms</div>
        
        <div class="diagram-container">
            <svg width="800" height="200" viewBox="0 0 800 200">
                <!-- Normal Cell -->
                <g>
                    <circle cx="120" cy="100" r="60" fill="#90EE90" opacity="0.3" stroke="#2d6a4f" stroke-width="2"/>
                    <text x="120" y="95" text-anchor="middle" font-size="16" font-weight="600" fill="#2d6a4f">Normal</text>
                    <text x="120" y="115" text-anchor="middle" font-size="16" font-weight="600" fill="#2d6a4f">Cell</text>
                    <text x="120" y="175" text-anchor="middle" font-size="13" fill="#555">Healthy pathways</text>
                </g>

                <!-- Mutation Arrow -->
                <g>
                    <path d="M 190 100 L 280 100" stroke="#ff6b6b" stroke-width="3" marker-end="url(#arrow-red)" stroke-dasharray="5,5"/>
                    <text x="235" y="90" text-anchor="middle" font-size="14" font-weight="600" fill="#ff6b6b">Mutation</text>
                </g>

                <!-- Disease Cell -->
                <g>
                    <circle cx="360" cy="100" r="60" fill="#ff6b6b" opacity="0.3" stroke="#c92a2a" stroke-width="2"/>
                    <text x="360" y="95" text-anchor="middle" font-size="16" font-weight="600" fill="#c92a2a">Disease</text>
                    <text x="360" y="115" text-anchor="middle" font-size="16" font-weight="600" fill="#c92a2a">Cell</text>
                    <text x="360" y="175" text-anchor="middle" font-size="13" fill="#555">Dysregulated pathways</text>
                </g>

                <!-- Target Arrow -->
                <g>
                    <path d="M 430 100 L 520 100" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrow-blue)" stroke-dasharray="5,5"/>
                    <text x="475" y="90" text-anchor="middle" font-size="14" font-weight="600" fill="#1E64C8">Target</text>
                </g>

                <!-- Target Protein -->
                <g>
                    <rect x="530" y="60" width="80" height="80" rx="10" fill="#ffd93d" opacity="0.4" stroke="#f59f00" stroke-width="2"/>
                    <text x="570" y="95" text-anchor="middle" font-size="32">üéØ</text>
                    <text x="570" y="120" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Key Protein</text>
                    <text x="570" y="175" text-anchor="middle" font-size="13" fill="#555">Therapeutic target</text>
                </g>

                <defs>
                    <marker id="arrow-red" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#ff6b6b"/>
                    </marker>
                    <marker id="arrow-blue" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#1E64C8"/>
                    </marker>
                </defs>
            </svg>
        </div>

        <div class="detail-section">
            <div class="detail-box">
                <div class="detail-title">Understanding Disease Biology</div>
                <div class="detail-text">
                    Disease mechanisms reveal how normal biological processes become disrupted, leading to pathological states. This understanding is fundamental for identifying potential therapeutic interventions.
                </div>
                <ul class="bullet-list">
                    <li><strong>Pathway Analysis:</strong> Identifying critical signaling cascades and metabolic pathways altered in disease</li>
                    <li><strong>Molecular Profiling:</strong> Using omics technologies (genomics, transcriptomics, proteomics) to map disease signatures</li>
                    <li><strong>Disease Models:</strong> Developing cell and animal models to study disease progression</li>
                </ul>
            </div>

            <div class="example-box">
                <div class="example-title">Example: Cancer Target Identification</div>
                <div class="example-text">
                    In HER2-positive breast cancer, amplification of the ERBB2 gene leads to overexpression of HER2 protein on cell surfaces. This drives uncontrolled cell proliferation through constant activation of growth signaling pathways. HER2 was identified as a therapeutic target, leading to the development of trastuzumab (Herceptin), which blocks HER2 signaling and has dramatically improved patient outcomes.
                </div>
            </div>
        </div>
    </div>

    <!-- Slide 3: Druggable Genome -->
    <div class="slide">
        <div class="subtitle">2. Druggable Genome</div>
        
        <div class="diagram-container">
            <svg width="800" height="220" viewBox="0 0 800 220">
                <!-- Genome -->
                <g>
                    <rect x="30" y="40" width="150" height="140" rx="10" fill="#e3f2fd" stroke="#1976d2" stroke-width="2"/>
                    <text x="105" y="30" text-anchor="middle" font-size="16" font-weight="600" fill="#1976d2">Human Genome</text>
                    <text x="105" y="70" text-anchor="middle" font-size="14" fill="#333">~20,000 genes</text>
                    <text x="105" y="110" text-anchor="middle" font-size="40">üß¨</text>
                    <text x="105" y="160" text-anchor="middle" font-size="13" fill="#555">All protein-coding</text>
                    <text x="105" y="175" text-anchor="middle" font-size="13" fill="#555">genes</text>
                </g>

                <!-- Arrow -->
                <path d="M 190 110 L 260 110" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrow-main)"/>
                <text x="225" y="100" text-anchor="middle" font-size="12" font-weight="600" fill="#1E64C8">Filter</text>

                <!-- Druggable Genome -->
                <g>
                    <rect x="270" y="40" width="150" height="140" rx="10" fill="#e8f5e9" stroke="#2e7d32" stroke-width="2"/>
                    <text x="345" y="30" text-anchor="middle" font-size="16" font-weight="600" fill="#2e7d32">Druggable Genome</text>
                    <text x="345" y="70" text-anchor="middle" font-size="14" fill="#333">~3,000 genes</text>
                    <text x="345" y="110" text-anchor="middle" font-size="40">üíä</text>
                    <text x="345" y="160" text-anchor="middle" font-size="13" fill="#555">Targetable by</text>
                    <text x="345" y="175" text-anchor="middle" font-size="13" fill="#555">small molecules</text>
                </g>

                <!-- Arrow -->
                <path d="M 430 110 L 500 110" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrow-main)"/>
                <text x="465" y="100" text-anchor="middle" font-size="12" font-weight="600" fill="#1E64C8">Select</text>

                <!-- Target Classes -->
                <g>
                    <rect x="510" y="20" width="260" height="180" rx="10" fill="#fff3e0" stroke="#e65100" stroke-width="2"/>
                    <text x="640" y="45" text-anchor="middle" font-size="15" font-weight="600" fill="#e65100">Major Target Classes</text>
                    
                    <text x="530" y="75" font-size="13" fill="#333">‚Ä¢ GPCRs (~800 genes)</text>
                    <text x="530" y="100" font-size="13" fill="#333">‚Ä¢ Kinases (~500 genes)</text>
                    <text x="530" y="125" font-size="13" fill="#333">‚Ä¢ Ion Channels (~400 genes)</text>
                    <text x="530" y="150" font-size="13" fill="#333">‚Ä¢ Nuclear Receptors (~50 genes)</text>
                    <text x="530" y="175" font-size="13" fill="#333">‚Ä¢ Proteases (~500 genes)</text>
                </g>

                <defs>
                    <marker id="arrow-main" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#1E64C8"/>
                    </marker>
                </defs>
            </svg>
        </div>

        <div class="detail-section">
            <div class="detail-box">
                <div class="detail-title">Identifying Targetable Proteins</div>
                <div class="detail-text">
                    The druggable genome represents the subset of human genes whose protein products can be modulated by drug-like small molecules or biologics. These proteins typically have binding pockets suitable for drug interaction.
                </div>
                <ul class="bullet-list">
                    <li><strong>Structural Features:</strong> Presence of binding sites accessible to small molecules or antibodies</li>
                    <li><strong>Functional Importance:</strong> Critical role in disease-relevant biological processes</li>
                    <li><strong>Chemical Tractability:</strong> Ability to be modulated by drug-like compounds with acceptable properties</li>
                </ul>
            </div>

            <div class="example-box">
                <div class="example-title">Example: Protein Kinases as Drug Targets</div>
                <div class="example-text">
                    Protein kinases represent one of the most successful druggable target classes. Imatinib (Gleevec) targets the BCR-ABL kinase in chronic myeloid leukemia. The ATP-binding pocket of kinases provides an ideal site for small molecule inhibitors. Over 70 kinase inhibitors have been approved, demonstrating the druggability of this protein family.
                </div>
            </div>
        </div>
    </div>

    <!-- Slide 4: Target Validation -->
    <div class="slide">
        <div class="subtitle">3. Target Validation</div>
        
        <div class="diagram-container">
            <svg width="800" height="200" viewBox="0 0 800 200">
                <!-- Validation Pyramid -->
                <g>
                    <!-- Level 1: In Silico -->
                    <polygon points="400,30 300,70 500,70" fill="#e3f2fd" stroke="#1976d2" stroke-width="2"/>
                    <text x="400" y="57" text-anchor="middle" font-size="13" font-weight="600" fill="#1976d2">In Silico</text>
                    
                    <!-- Level 2: In Vitro -->
                    <polygon points="400,75 250,115 550,115" fill="#c5e1a5" stroke="#558b2f" stroke-width="2"/>
                    <text x="400" y="100" text-anchor="middle" font-size="13" font-weight="600" fill="#558b2f">In Vitro (Cell-based)</text>
                    
                    <!-- Level 3: In Vivo -->
                    <polygon points="400,120 200,160 600,160" fill="#fff9c4" stroke="#f57f17" stroke-width="2"/>
                    <text x="400" y="145" text-anchor="middle" font-size="13" font-weight="600" fill="#f57f17">In Vivo (Animal models)</text>
                    
                    <!-- Level 4: Clinical -->
                    <polygon points="400,165 150,200 650,200" fill="#ffccbc" stroke="#d84315" stroke-width="2"/>
                    <text x="400" y="187" text-anchor="middle" font-size="13" font-weight="600" fill="#d84315">Clinical Validation</text>
                </g>

                <!-- Side annotations -->
                <g>
                    <text x="670" y="50" font-size="12" fill="#666">Bioinformatics</text>
                    <text x="670" y="95" font-size="12" fill="#666">Biochemical assays</text>
                    <text x="670" y="140" font-size="12" fill="#666">Disease models</text>
                    <text x="670" y="183" font-size="12" fill="#666">Human studies</text>
                </g>

                <!-- Confidence arrow -->
                <g>
                    <line x1="50" y1="200" x2="50" y2="30" stroke="#f44336" stroke-width="3" marker-end="url(#arrow-conf)"/>
                    <text x="35" y="120" font-size="13" font-weight="600" fill="#f44336" transform="rotate(-90 35 120)">Confidence Level</text>
                </g>

                <defs>
                    <marker id="arrow-conf" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#f44336"/>
                    </marker>
                </defs>
            </svg>
        </div>

        <div class="detail-section">
            <div class="detail-box">
                <div class="detail-title">Confirming Therapeutic Relevance</div>
                <div class="detail-text">
                    Target validation is the process of demonstrating that modulating a specific target will produce the desired therapeutic effect. This reduces the risk of failure in later drug development stages.
                </div>
                <ul class="bullet-list">
                    <li><strong>Genetic Approaches:</strong> Using CRISPR, RNAi, or knockout models to assess target function</li>
                    <li><strong>Chemical Validation:</strong> Using tool compounds or existing drugs to probe target effects</li>
                    <li><strong>Biomarker Studies:</strong> Identifying measurable indicators of target engagement and efficacy</li>
                    <li><strong>Clinical Evidence:</strong> Human genetic data linking target to disease outcomes</li>
                </ul>
            </div>

            <div class="example-box">
                <div class="example-title">Example: PCSK9 Validation</div>
                <div class="example-text">
                    PCSK9 was validated as a target for cholesterol lowering through multiple lines of evidence: (1) Human genetics showed loss-of-function mutations in PCSK9 associated with low LDL-cholesterol and reduced cardiovascular risk; (2) Animal studies confirmed that PCSK9 knockout reduced cholesterol; (3) Mechanistic studies revealed PCSK9 promotes degradation of LDL receptors. This strong validation supported development of PCSK9 inhibitors, now approved for high cholesterol treatment.
                </div>
            </div>
        </div>
    </div>

    <!-- Slide 5: Genetic Evidence -->
    <div class="slide">
        <div class="subtitle">4. Genetic Evidence</div>
        
        <div class="diagram-container">
            <svg width="800" height="200" viewBox="0 0 800 200">
                <!-- GWAS Studies -->
                <g>
                    <rect x="30" y="40" width="160" height="120" rx="10" fill="#e1f5fe" stroke="#0277bd" stroke-width="2"/>
                    <text x="110" y="30" text-anchor="middle" font-size="14" font-weight="600" fill="#0277bd">GWAS</text>
                    <text x="110" y="75" text-anchor="middle" font-size="32">üìä</text>
                    <text x="110" y="105" text-anchor="middle" font-size="12" fill="#333">Genome-wide</text>
                    <text x="110" y="120" text-anchor="middle" font-size="12" fill="#333">association</text>
                    <text x="110" y="135" text-anchor="middle" font-size="12" fill="#333">studies</text>
                    <text x="110" y="155" text-anchor="middle" font-size="11" fill="#666">Population variants</text>
                </g>

                <!-- Rare Variants -->
                <g>
                    <rect x="220" y="40" width="160" height="120" rx="10" fill="#f3e5f5" stroke="#6a1b9a" stroke-width="2"/>
                    <text x="300" y="30" text-anchor="middle" font-size="14" font-weight="600" fill="#6a1b9a">Rare Variants</text>
                    <text x="300" y="75" text-anchor="middle" font-size="32">üß¨</text>
                    <text x="300" y="105" text-anchor="middle" font-size="12" fill="#333">Exome/genome</text>
                    <text x="300" y="120" text-anchor="middle" font-size="12" fill="#333">sequencing</text>
                    <text x="300" y="135" text-anchor="middle" font-size="12" fill="#333">studies</text>
                    <text x="300" y="155" text-anchor="middle" font-size="11" fill="#666">Loss/gain function</text>
                </g>

                <!-- Mendelian Disease -->
                <g>
                    <rect x="410" y="40" width="160" height="120" rx="10" fill="#fff3e0" stroke="#e65100" stroke-width="2"/>
                    <text x="490" y="30" text-anchor="middle" font-size="14" font-weight="600" fill="#e65100">Mendelian</text>
                    <text x="490" y="75" text-anchor="middle" font-size="32">üë®‚Äçüë©‚Äçüëß‚Äçüë¶</text>
                    <text x="490" y="105" text-anchor="middle" font-size="12" fill="#333">Family-based</text>
                    <text x="490" y="120" text-anchor="middle" font-size="12" fill="#333">inheritance</text>
                    <text x="490" y="135" text-anchor="middle" font-size="12" fill="#333">patterns</text>
                    <text x="490" y="155" text-anchor="middle" font-size="11" fill="#666">Causal mutations</text>
                </g>

                <!-- Drug Response -->
                <g>
                    <rect x="600" y="40" width="160" height="120" rx="10" fill="#e8f5e9" stroke="#2e7d32" stroke-width="2"/>
                    <text x="680" y="30" text-anchor="middle" font-size="14" font-weight="600" fill="#2e7d32">Pharmacogenetics</text>
                    <text x="680" y="75" text-anchor="middle" font-size="32">üíä</text>
                    <text x="680" y="105" text-anchor="middle" font-size="12" fill="#333">Drug response</text>
                    <text x="680" y="120" text-anchor="middle" font-size="12" fill="#333">genetics</text>
                    <text x="680" y="135" text-anchor="middle" font-size="12" fill="#333">studies</text>
                    <text x="680" y="155" text-anchor="middle" font-size="11" fill="#666">Target validation</text>
                </g>
            </svg>
        </div>

        <div class="detail-section">
            <div class="detail-box">
                <div class="detail-title">Human Genetics Support</div>
                <div class="detail-text">
                    Human genetic evidence provides powerful validation for drug targets. Drugs with genetic support are twice as likely to succeed in clinical development compared to those without such evidence.
                </div>
                <ul class="bullet-list">
                    <li><strong>Natural Experiments:</strong> Human genetic variants that mimic drug effects predict therapeutic outcomes</li>
                    <li><strong>Disease Association:</strong> Genetic variants in target genes linked to disease risk or protection</li>
                    <li><strong>Dose-Response Relationships:</strong> Correlation between variant effect size and phenotype severity</li>
                    <li><strong>Safety Insights:</strong> Rare individuals with loss-of-function variants reveal safety profile</li>
                </ul>
            </div>

            <div class="example-box">
                <div class="example-title">Example: APOC3 and Triglycerides</div>
                <div class="example-text">
                    Human genetics revealed that loss-of-function mutations in APOC3 are associated with 40% lower triglyceride levels and 40% reduced risk of coronary heart disease. Importantly, individuals with these mutations show no adverse effects, suggesting that inhibiting APOC3 would be safe and effective. This genetic evidence strongly supported development of antisense oligonucleotides targeting APOC3, with volanesorsen approved for familial chylomicronemia syndrome.
                </div>
            </div>
        </div>
    </div>

    <!-- Slide 6: Network Approaches -->
    <div class="slide">
        <div class="subtitle">5. Network Approaches</div>
        
        <div class="diagram-container">
            <svg width="800" height="200" viewBox="0 0 800 200">
                <!-- Network visualization -->
                <g>
                    <!-- Central disease node -->
                    <circle cx="400" cy="100" r="35" fill="#ff6b6b" opacity="0.4" stroke="#c92a2a" stroke-width="3"/>
                    <text x="400" y="105" text-anchor="middle" font-size="14" font-weight="600" fill="#c92a2a">Disease</text>

                    <!-- Target nodes around -->
                    <circle cx="280" cy="60" r="25" fill="#4ecdc4" opacity="0.5" stroke="#0ca678" stroke-width="2"/>
                    <text x="280" y="65" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Target A</text>

                    <circle cx="280" cy="140" r="25" fill="#4ecdc4" opacity="0.5" stroke="#0ca678" stroke-width="2"/>
                    <text x="280" y="145" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Target B</text>

                    <circle cx="520" cy="60" r="25" fill="#4ecdc4" opacity="0.5" stroke="#0ca678" stroke-width="2"/>
                    <text x="520" y="65" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Target C</text>

                    <circle cx="520" cy="140" r="25" fill="#4ecdc4" opacity="0.5" stroke="#0ca678" stroke-width="2"/>
                    <text x="520" y="145" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Target D</text>

                    <circle cx="400" cy="30" r="20" fill="#ffd93d" opacity="0.5" stroke="#f59f00" stroke-width="2"/>
                    <text x="400" y="35" text-anchor="middle" font-size="10" font-weight="600" fill="#f59f00">Gene E</text>

                    <circle cx="400" cy="170" r="20" fill="#ffd93d" opacity="0.5" stroke="#f59f00" stroke-width="2"/>
                    <text x="400" y="175" text-anchor="middle" font-size="10" font-weight="600" fill="#f59f00">Gene F</text>

                    <!-- Connections -->
                    <line x1="365" y1="75" x2="305" y2="75" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>
                    <line x1="365" y1="125" x2="305" y2="125" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>
                    <line x1="435" y1="75" x2="495" y2="75" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>
                    <line x1="435" y1="125" x2="495" y2="125" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>
                    <line x1="400" y1="65" x2="400" y2="50" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>
                    <line x1="400" y1="135" x2="400" y2="150" stroke="#1E64C8" stroke-width="2" opacity="0.6"/>

                    <!-- Additional connections between targets -->
                    <line x1="280" y1="85" x2="280" y2="115" stroke="#95e1d3" stroke-width="1.5" opacity="0.4" stroke-dasharray="3,3"/>
                    <line x1="520" y1="85" x2="520" y2="115" stroke="#95e1d3" stroke-width="1.5" opacity="0.4" stroke-dasharray="3,3"/>
                    <line x1="305" y1="70" x2="375" y2="40" stroke="#95e1d3" stroke-width="1.5" opacity="0.4" stroke-dasharray="3,3"/>
                </g>

                <!-- Legend -->
                <g>
                    <rect x="620" y="30" width="150" height="140" rx="8" fill="#f8f9fa" stroke="#dee2e6" stroke-width="1"/>
                    <text x="695" y="50" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Network Elements</text>
                    
                    <circle cx="640" cy="70" r="8" fill="#ff6b6b" opacity="0.6"/>
                    <text x="655" y="75" font-size="11" fill="#333">Disease node</text>
                    
                    <circle cx="640" cy="95" r="8" fill="#4ecdc4" opacity="0.6"/>
                    <text x="655" y="100" font-size="11" fill="#333">Target proteins</text>
                    
                    <circle cx="640" cy="120" r="8" fill="#ffd93d" opacity="0.6"/>
                    <text x="655" y="125" font-size="11" fill="#333">Related genes</text>
                    
                    <line x1="635" y1="145" x2="655" y2="145" stroke="#1E64C8" stroke-width="2"/>
                    <text x="660" y="150" font-size="11" fill="#333">Interactions</text>
                </g>
            </svg>
        </div>

        <div class="detail-section">
            <div class="detail-box">
                <div class="detail-title">Systems Biology Integration</div>
                <div class="detail-text">
                    Network approaches analyze biological systems as interconnected networks rather than isolated components. This reveals disease mechanisms and identifies optimal intervention points that traditional reductionist approaches might miss.
                </div>
                <ul class="bullet-list">
                    <li><strong>Protein-Protein Interactions:</strong> Mapping physical and functional relationships between proteins</li>
                    <li><strong>Pathway Enrichment:</strong> Identifying overrepresented biological processes in disease networks</li>
                    <li><strong>Network Topology:</strong> Finding hub proteins and key regulatory nodes as potential targets</li>
                    <li><strong>Multi-omics Integration:</strong> Combining genomic, transcriptomic, proteomic, and metabolomic data</li>
                </ul>
            </div>

            <div class="example-box">
                <div class="example-title">Example: Alzheimer's Disease Network Analysis</div>
                <div class="example-text">
                    Network analysis of Alzheimer's disease brain tissue revealed that while APP and PSEN1 mutations are well-known causes, network hub proteins like TYROBP and TREM2 in microglial cells play critical roles in disease progression. This network approach identified novel immune-related targets beyond the traditional amyloid hypothesis. TREM2 variants were subsequently found to increase Alzheimer's risk, validating the network prediction and opening new therapeutic avenues targeting neuroinflammation.
                </div>
            </div>
        </div>
    </div>

    <!-- Slide 7: Integration Summary -->
    <div class="slide">
        <div class="subtitle">Integration of Target Identification Strategies</div>
        
        <div class="diagram-container">
            <svg width="800" height="280" viewBox="0 0 800 280">
                <!-- Center: Validated Target -->
                <g>
                    <circle cx="400" cy="140" r="50" fill="#4caf50" opacity="0.3" stroke="#2e7d32" stroke-width="3"/>
                    <text x="400" y="135" text-anchor="middle" font-size="16" font-weight="700" fill="#2e7d32">Validated</text>
                    <text x="400" y="155" text-anchor="middle" font-size="16" font-weight="700" fill="#2e7d32">Target</text>
                    <text x="400" y="210" text-anchor="middle" font-size="13" fill="#333">High confidence</text>
                    <text x="400" y="225" text-anchor="middle" font-size="13" fill="#333">for drug development</text>
                </g>

                <!-- Five input circles -->
                <!-- Disease Mechanism -->
                <g>
                    <circle cx="220" cy="50" r="40" fill="#ff6b6b" opacity="0.2" stroke="#c92a2a" stroke-width="2"/>
                    <text x="220" y="50" text-anchor="middle" font-size="11" font-weight="600" fill="#c92a2a">Disease</text>
                    <text x="220" y="63" text-anchor="middle" font-size="11" font-weight="600" fill="#c92a2a">Mechanism</text>
                    <path d="M 250 80 L 370 115" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow-int)" opacity="0.7"/>
                </g>

                <!-- Druggable Genome -->
                <g>
                    <circle cx="580" cy="50" r="40" fill="#4ecdc4" opacity="0.2" stroke="#0ca678" stroke-width="2"/>
                    <text x="580" y="50" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Druggable</text>
                    <text x="580" y="63" text-anchor="middle" font-size="11" font-weight="600" fill="#0ca678">Genome</text>
                    <path d="M 550 80 L 430 115" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow-int)" opacity="0.7"/>
                </g>

                <!-- Validation -->
                <g>
                    <circle cx="150" cy="200" r="40" fill="#a8dadc" opacity="0.2" stroke="#457b9d" stroke-width="2"/>
                    <text x="150" y="200" text-anchor="middle" font-size="11" font-weight="600" fill="#457b9d">Target</text>
                    <text x="150" y="213" text-anchor="middle" font-size="11" font-weight="600" fill="#457b9d">Validation</text>
                    <path d="M 190 180 L 350 155" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow-int)" opacity="0.7"/>
                </g>

                <!-- Genetics -->
                <g>
                    <circle cx="400" cy="260" r="40" fill="#9c27b0" opacity="0.2" stroke="#6a1b9a" stroke-width="2"/>
                    <text x="400" y="260" text-anchor="middle" font-size="11" font-weight="600" fill="#6a1b9a">Genetic</text>
                    <text x="400" y="273" text-anchor="middle" font-size="11" font-weight="600" fill="#6a1b9a">Evidence</text>
                    <path d="M 400 220 L 400 190" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow-int)" opacity="0.7"/>
                </g>

                <!-- Networks -->
                <g>
                    <circle cx="650" cy="200" r="40" fill="#f4a261" opacity="0.2" stroke="#e76f51" stroke-width="2"/>
                    <text x="650" y="200" text-anchor="middle" font-size="11" font-weight="600" fill="#e76f51">Network</text>
                    <text x="650" y="213" text-anchor="middle" font-size="11" font-weight="600" fill="#e76f51">Analysis</text>
                    <path d="M 610 180 L 450 155" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrow-int)" opacity="0.7"/>
                </g>

                <defs>
                    <marker id="arrow-int" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#1E64C8"/>
                    </marker>
                </defs>
            </svg>
        </div>

        <div class="key-point">
            <div class="key-point-text">
                Success in target identification requires convergent evidence from multiple complementary approaches
            </div>
        </div>

        <div class="detail-section" style="margin-top: 15px;">
            <div class="detail-box">
                <div class="detail-title">Best Practices for Target Selection</div>
                <ul class="bullet-list">
                    <li><strong>Multiple Lines of Evidence:</strong> Targets supported by several independent validation methods have higher success rates</li>
                    <li><strong>Human Genetic Support:</strong> Prioritize targets with strong human genetic evidence linking them to disease</li>
                    <li><strong>Druggability Assessment:</strong> Consider structural features and chemical tractability early in the process</li>
                    <li><strong>Safety Considerations:</strong> Evaluate potential on-target and off-target effects using available data</li>
                    <li><strong>Biomarker Strategy:</strong> Develop measurable endpoints for target engagement and pharmacodynamic effects</li>
                </ul>
            </div>
        </div>
    </div>

</body>
</html>